Green Cross Holdings Corporation (KRX:005257)

Market Cap	639.71B -1.2%
Revenue (ttm)	2.40T +9.9%
Net Income	127.58B
EPS	2,832.40
Shares Out	n/a
PE Ratio	5.01
Forward PE	n/a
Dividend	300.00 (1.25%)
Ex-Dividend Date	Mar 30, 2026

Volume	34
Average Volume	808
Open	24,150
Previous Close	24,050
Day's Range	23,650 - 24,150
52-Week Range	18,300 - 73,900
Beta	0.56
RSI	48.84
Earnings Date	Mar 20, 2026

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005257